Compounds > dronabinol

Page last updated: 2024-08-21

dronabinol and Atherosclerosis

dronabinol has been researched along with Atherosclerosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amamoto, T; Aramaki, H; Eyanagi, R; Imoto, M; Jiang, R; Takeda, S; Toda, A; Watanabe, K; Yamamoto, I	1
Mach, F; Steffens, S	2

Reviews

2 review(s) available for dronabinol and Atherosclerosis

Article	Year
[Toward a therapeutic use of cannabinoid CB(2) receptor in atherosclerosis]. Medecine sciences : M/S, 2006, Volume: 22, Issue:1 Topics: Analgesics, Non-Narcotic; Atherosclerosis; Cannabinoids; Dronabinol; Humans; Psychotropic Drugs; Receptor, Cannabinoid, CB2	2006
Cannabinoid receptors in atherosclerosis. Current opinion in lipidology, 2006, Volume: 17, Issue:5 Topics: Animals; Atherosclerosis; Cannabinoids; Chemotaxis; Dronabinol; Humans; Immunologic Factors; Mice; Models, Biological; Receptors, Cannabinoid	2006

Other Studies

1 other study(ies) available for dronabinol and Atherosclerosis

Article	Year
Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors. Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:3 Topics: Arachidonate 15-Lipoxygenase; Atherosclerosis; Dronabinol; Humans; Lipoxygenase Inhibitors; Molecular Targeted Therapy; Receptor, Cannabinoid, CB2	2011